Sonos, Inc. (SONO)

Theseus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 29, 2025	Sep 28, 2024	Sep 30, 2023	Oct 1, 2022	Oct 2, 2021	Oct 3, 2020
Revenue	1,463	1,518	1,655	1,752	1,717	1,326
Revenue Growth (YoY)	-5.24%	-8.29%	-5.54%	2.07%	29.44%	5.20%
Cost of Revenue	809.53	828.68	938.77	955.97	906.75	754.37
Gross Profit	653.61	689.37	716.49	796.37	809.99	571.96
Selling, General & Admin	403.47	426.75	426.94	450.76	424.95	384.52
Research & Development	285.14	298.82	294.45	256.07	230.08	214.67
Operating Expenses	688.6	725.57	721.39	706.84	655.03	599.19
Operating Income	-34.99	-36.19	-4.9	89.53	154.96	-27.23
Interest Expense	-0.43	-0.44	-0.73	-0.55	-0.59	-1.49
Interest & Investment Income	8.79	11.97	10.2	1.66	0.15	2
Currency Exchange Gain (Loss)	-3.54	9.06	13.67	-21.88	2.35	6.59
Other Non Operating Income (Expenses)	0.1	0.31	1.8	-0.03	0.05	0.05
EBT Excluding Unusual Items	-30.07	-15.3	20.04	68.73	156.93	-20.08
Merger & Restructuring Charges	-34.92	-11.85	-15.65	-	-	-
Pretax Income	-64.99	-27.15	4.39	68.73	156.93	-20.08
Income Tax Expense	4.3	11	14.67	1.35	-1.67	0.03
Net Income	-69.29	-38.15	-10.27	67.38	158.6	-20.12
Net Income to Common	-69.29	-38.15	-10.27	67.38	158.6	-20.12
Net Income Growth	-	-	-	-57.51%	-	-
Shares Outstanding (Basic)	121	123	128	128	122	110
Shares Outstanding (Diluted)	121	123	128	138	140	110
Shares Change (YoY)	-3.69%	-3.51%	-7.30%	-1.81%	27.78%	5.80%
EPS (Basic)	-0.57	-0.31	-0.08	0.53	1.30	-0.18
EPS (Diluted)	-0.57	-0.31	-0.08	0.49	1.13	-0.18
EPS Growth	-	-	-	-56.64%	-	-
Free Cash Flow	64.61	134.66	50.12	-74.48	207.7	128.95
Free Cash Flow Per Share	0.53	1.09	0.39	-0.54	1.48	1.17
Gross Margin	44.67%	45.41%	43.29%	45.45%	47.18%	43.12%
Operating Margin	-2.39%	-2.38%	-0.30%	5.11%	9.03%	-2.05%
Profit Margin	-4.74%	-2.51%	-0.62%	3.84%	9.24%	-1.52%
Free Cash Flow Margin	4.42%	8.87%	3.03%	-4.25%	12.10%	9.72%
EBITDA	23.54	12.69	40.37	128.04	188.85	9.19
EBITDA Margin	1.61%	0.84%	2.44%	7.31%	11.00%	0.69%
D&A For EBITDA	58.54	48.88	45.27	38.5	33.88	36.43
EBIT	-34.99	-36.19	-4.9	89.53	154.96	-27.23
EBIT Margin	-2.39%	-2.38%	-0.30%	5.11%	9.03%	-2.05%
Effective Tax Rate	-	-	333.82%	1.96%	-	-
Advertising Expenses	-	55.8	43.9	66.6	62.3	43.9

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q